Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from CURLF

3 Cannabis Stocks to Buy Before the Next Catalyst Hits

The cannabis industry is poised for significant growth, driven by expanding legalization and potential regulatory reforms. Three stocks that analysts believe are well-positioned to benefit from upcoming catalysts are Curaleaf Holdings, Verano Holdings, and AFC Gamma.

Barchart

1 Growth Stock Under $10 to Buy and Hold

Amidst the DEA's anticipated rescheduling of marijuana, Curaleaf Holdings emerges as a compelling growth stock under $10, buoyed by strategic expansions, regulatory tailwinds, and bullish analyst forecasts in the flourishing cannabis industry.

Barchart

3 Cannabis Stocks With More Upside Potential Than Canopy Growth

Three lesser-known cannabis companies are quietly making moves that could position them as more attractive investment opportunities than the headline-grabbing Canopy Growth.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Cannabis Stocks Under $5 to Consider as the DEA Reviews Drug Status

As the DEA reviews the federal classification of marijuana, here's what investors need to know about these three cannabis stocks under $5.

Barchart

Which Pharma Stock Is the Better July Pick: Johnson & Johnson (JNJ) or Curaleaf Holdings (CURLF)?

On the backs of increasing medical requirements amid the soaring incidence of chronic diseases, the pharmaceutical industry’s outlook radiates promise. Given this backdrop, let us compare pharma stocks Johnson & Johnson (JNJ) and Curaleaf Holdings (CURLF) to discover which one of these could be worth buying in July. Read on….

StockNews.com

3 Cannabis Stocks to Avoid Despite the Legalization Momentum in 2023

Despite legalization gaining traction, the cannabis industry's prospects for the year ahead remain grim due to several economic and industry-wide headwinds. As a result, it seems wise to avoid sinking cannabis stocks Curaleaf Holdings (CURLF), Tilray Brands (TLRY), and Verano Holdings (VRNOF). Read more….

StockNews.com

Curaleaf Reports Second Quarter 2022 Results, Chairman Boris Jordan Says Fundamentals Are Strong

Recently, Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) reported its financial and operating results for the second quarter, ended June 30, 2022.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Curaleaf International Registers Range Of Proprietary THC/CBD Cannabis Oil Product Formulations In Malta

Curaleaf International, a division of Curaleaf Holdings (OTCQX: CURLF) (CNSX:CURA), announced the successful license of the company’s range of cannabis based medicines as extract, under the name Adven, in Malta.

Benzinga

Curaleaf Appoints Neil Davidson As Interim Chief Financial Officer

Curaleaf Holdings, Inc. (OTCQX: CURLF)(CSE:CURA) has appointed Neil Davidson as interim chief financial officer, effective March 14, 2022.

Benzinga

Curaleaf To Open Its 45th Florida Cannabis Dispensary In Tamarac

Curaleaf Holdings, Inc. (OTCQX: CURLF) (CSE:CURA) announced the opening of its newest location in Tamarac, Florida. Curaleaf Tamarac is the company's 45th location in Florida and the second in Broward County.

Benzinga

Curaleaf's Cannabis Brand Select Expands Product Offerings With Live Rosin Solventless Extracts

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has launched Select Live Rosin, its first line of solventless extracts, to patients across Florida.

Benzinga

Curaleaf Reports Q4 Revenue, Net Loss Narrows As Revenue Surges 39% YoY To $320M

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) reported its financial and operating results for the fourth quarter and year ended December 31, 2021.

Benzinga

Leaf Trade Announces National Partnership With Curaleaf, Starting With New York

Wholesale cannabis marketplace Leaf Trade, Inc. announced a national partnership with Curaleaf Holdings, Inc. (CSE:CURA) (OTCQX:CURLF).

Benzinga

Curaleaf & Repsly Enter Into New Retail Technology Partnership

Tech platform Repsly announced that it has entered into a technology partnership agreement with Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF).

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Beaten-Down Cannabis Stocks That Will More Than Double, According to Wall Street

Cannabis stocks have plunged so far this year due to broader market selloff and delays in cannabis federal legislation. However, given the bolstering growth outlook for this industry, Wall Street analysts are betting on Curaleaf Holding (CURLF), Trulieve Cannabis (TCNNF), Sundial Growers (SNDL), and HEXO Corp. (HEXO) to surge in…

Benzinga

When Is Curaleaf Reporting Earnings? Cannabis Co. Changes Date Of Q4 & FY2021 Earnings Conference Call

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), an international provider of consumer products in cannabis, announced that it will report its financial and operating results for the fourth quarter and fiscal year ended December 31, 2021 after market close on March 3, 2022.

Benzinga

Cannabis Dispensary Roundup: Curaleaf Expands In Florida & PA, Sweet Flower Opens Shop In Culver City

Curaleaf Holdings Opens New Stores In Florida & Pennsylvania Cannabis company Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) bolstered its retail footprint in Florida and Pennsylvania last week.

Benzinga

Curaleaf Expands In Pennsylvania With Two New Cannabis Dispensaries In Greensburg And Wayne

Cannabis company Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) announced on Thursday that it plans to open two new dispensaries in Pennsylvania.

Get all your
news in one place.

100’s of premium titles.
One news app.

Kiplinger

Best Marijuana Stocks to Buy: Cannabis Stocks for Investing

The best marijuana stocks have been put through the wringer for years. But with U.S. cannabis sales on the rise, these picks could finally have their day in the sun.

People

Kamala Harris

13,889 stories

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Medical Pharmaceuticals

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.